Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-067067
Date:2021-11-24
Issuer: MIRUM PHARMACEUTICALS, INC. (MIRM)
Original Submission Date:

Reporting Person:

PEETZ CHRISTOPHER
C/O MIRUM PHARMACEUTICALS, INC.
950 TOWER LANE, SUITE 1050 FOSTER CITY, CA 94404

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-11-24 P 7,000 a $14.40 28,027 direct
COMMON STOCK 2021-11-24 0 $0.00 201,570 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the reporting person's purchase of mirm common stock reported herein was matchable under section 16(b) of the securities exchange act of 1934 with the reporting person's sale of 3,672 shares of mirm common stock on october 1, 2021 at a price of $19.256. the transaction resulted in short-swing profits of $17,831.23 which the reporting person has disgorged to mirm in accordance with section 16(b) of the securities exchange act of 1934.
WhaleWisdom Logo

Elevate your investments